Skip to content

AI assisted total hip arthroplasty

AI assisted total hip arthroplasty

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053071
Enrollment
Unknown
Registered
2021-11-10
Start date
2021-11-30
Completion date
Unknown
Last updated
2022-09-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total hip arthroplasty

Interventions

Research group:Before surgery, the prosthesis was determined by film template measurement and placed by the surgeon based on personal experience
Control group:Before surgery, AIHIP software was used to design and install the prosthesis of the type determined by AIHIP software

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients who need primary unilateral THA due to severe osteoarthritis of the hip; 2.Aged is 18 to 80 years; 3.Preoperative American Society of Anesthesiologists (ASA) classification (anesthesia risk assessment) was grade I~III.

Exclusion criteria

Exclusion criteria: 1.Body mass index (BMI) >35kg/m^2; 2.Patients with heart, lung and other important organ failure; 3.Abnormal liver and kidney function (ALT, AST> normal value 1.5 times, blood BUN>-8.3 mmoll, blood Scr>115 umol/L); 4.Diabetic patients with poor control of blood sugar level; researchers judged risk of infection; 5.Combined with consciousness disorder or mental illness; 6.Had a history of open hip surgery; 7.Neuromuscular dysfunction affecting lower limb function; 8.Patients with severe coagulation dysfunction; 9.Complicated with severe internal and surgical diseases or weak physique, unable to tolerate the operation; 10.Severe instability that cannot be cured with THA; 11.Active infection foci in the body (whole body or local infectious lesions); 12.There are serious osteoporosis, metabolic bone disease, radiation bone disease and tumor around the hip; 13.Family planning, lactation and pregnant women during the whole clinical study; 14.Patients who have participated in other clinical trials within 3 months; 15.Patients who the researchers think are not suitable to participate in this clinical trial for other reasons.

Design outcomes

Primary

MeasureTime frame
Acetabular abduction angle;Acetabular anteversion;Angle between shaft of femur and axis of medullary cavity;Femoral offset;

Secondary

MeasureTime frame
Length difference between lower limbs;Evaluation index of joint function;Time of operation;The total blood loss;

Countries

China

Contacts

Public ContactKang Pengde

West China Hospital of Sichuan University

kangpd@163.com+86 18980601953

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026